DE69929476D1 - 5-ä(6-(2-fluorbenzyl)oxy-2-naphtyl)methylü-thiazolid in-2,4-dion kristallen - Google Patents

5-ä(6-(2-fluorbenzyl)oxy-2-naphtyl)methylü-thiazolid in-2,4-dion kristallen

Info

Publication number
DE69929476D1
DE69929476D1 DE69929476T DE69929476T DE69929476D1 DE 69929476 D1 DE69929476 D1 DE 69929476D1 DE 69929476 T DE69929476 T DE 69929476T DE 69929476 T DE69929476 T DE 69929476T DE 69929476 D1 DE69929476 D1 DE 69929476D1
Authority
DE
Germany
Prior art keywords
naphtyl
oxy
crystals
methylu
fluorbenzyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69929476T
Other languages
English (en)
Other versions
DE69929476T2 (de
Inventor
Takayuki Oe
Hiroaki Ueno
Akira Maruyama
Katsuhiko Masuda
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mitsubishi Chemical Corp
Original Assignee
Mitsubishi Chemical Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mitsubishi Chemical Corp filed Critical Mitsubishi Chemical Corp
Publication of DE69929476D1 publication Critical patent/DE69929476D1/de
Application granted granted Critical
Publication of DE69929476T2 publication Critical patent/DE69929476T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/34—Oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pain & Pain Management (AREA)
  • Endocrinology (AREA)
  • Oncology (AREA)
  • Emergency Medicine (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Photoreceptors In Electrophotography (AREA)
  • Cosmetics (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
DE69929476T 1998-11-20 1999-11-19 5-ä(6-(2-fluorbenzyl)oxy-2-naphtyl)methylü-thiazolid in-2,4-dion kristallen Expired - Fee Related DE69929476T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP33054698 1998-11-20
JP33054698 1998-11-20
PCT/JP1999/006492 WO2000031055A1 (en) 1998-11-20 1999-11-19 Chrystals of 5-[{6-(2-fluorobenzyl)oxy-2-naphthyl}methyl]-2,4-thiazolidinedione

Publications (2)

Publication Number Publication Date
DE69929476D1 true DE69929476D1 (de) 2006-04-06
DE69929476T2 DE69929476T2 (de) 2006-09-14

Family

ID=18233859

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69929476T Expired - Fee Related DE69929476T2 (de) 1998-11-20 1999-11-19 5-ä(6-(2-fluorbenzyl)oxy-2-naphtyl)methylü-thiazolid in-2,4-dion kristallen

Country Status (23)

Country Link
US (3) US6541493B1 (de)
EP (1) EP1131310B1 (de)
JP (1) JP3784001B2 (de)
KR (1) KR100652326B1 (de)
CN (1) CN1326449A (de)
AT (1) ATE315552T1 (de)
AU (1) AU1185100A (de)
BR (1) BR9916795A (de)
CA (1) CA2351727C (de)
CZ (1) CZ20011763A3 (de)
DE (1) DE69929476T2 (de)
ES (1) ES2257104T3 (de)
HU (1) HUP0104139A3 (de)
ID (1) ID30064A (de)
IL (1) IL143177A0 (de)
NO (1) NO20012444L (de)
NZ (1) NZ512429A (de)
PL (1) PL348502A1 (de)
PT (1) PT1131310E (de)
TR (4) TR200202110T2 (de)
TW (2) TWI250156B (de)
WO (1) WO2000031055A1 (de)
ZA (1) ZA200104081B (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL348502A1 (en) * 1998-11-20 2002-05-20 Mitsubishi Chem Corp Chrystals of 5-[{6-(2-fluorobenzyl)oxy-2-naphthyl}methyl]-2,4-thiazolidinedione
WO2001036401A1 (en) * 1999-11-19 2001-05-25 Ortho-Mcneil Pharmaceutical, Inc. Solid state forms of 5-[[6-[(2-fluorophenyl)methoxy]-2-naphthalenyl]methyl]-2,4-thiazolidinedione
WO2002080936A1 (en) * 2001-04-04 2002-10-17 Ortho Mcneil Pharmaceutical, Inc. Combination therapy comprising glucose reabsorption inhibitors and ppar modulators
WO2007049050A2 (en) * 2005-10-27 2007-05-03 Heptahelix Ab Modulators of gpr40 for the treatment of diabetes
BRPI0907463A2 (pt) * 2008-02-04 2019-09-24 Pfizer Ltd forma polimórfica de um derivado de [1,2,4] triazol [4,3-a] piridina para tratamento de doenças inflamatórias

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5594016A (en) * 1992-12-28 1997-01-14 Mitsubishi Chemical Corporation Naphthalene derivatives
JP2845743B2 (ja) * 1992-12-28 1999-01-13 三菱化学株式会社 新規なナフタレン誘導体
JP4023697B2 (ja) 1996-11-14 2007-12-19 三菱化学株式会社 ナフタレン誘導体の製造方法
PL348502A1 (en) * 1998-11-20 2002-05-20 Mitsubishi Chem Corp Chrystals of 5-[{6-(2-fluorobenzyl)oxy-2-naphthyl}methyl]-2,4-thiazolidinedione

Also Published As

Publication number Publication date
TWI272944B (en) 2007-02-11
TR200202110T2 (tr) 2002-10-21
ES2257104T3 (es) 2006-07-16
BR9916795A (pt) 2002-04-09
JP3784001B2 (ja) 2006-06-07
TW200613291A (en) 2006-05-01
TR200101901T2 (tr) 2002-04-22
CZ20011763A3 (cs) 2001-10-17
EP1131310A1 (de) 2001-09-12
CA2351727C (en) 2008-09-23
KR100652326B1 (ko) 2006-11-29
NZ512429A (en) 2003-11-28
NO20012444L (no) 2001-07-18
JP2002530392A (ja) 2002-09-17
EP1131310B1 (de) 2006-01-11
WO2000031055A1 (en) 2000-06-02
HUP0104139A2 (hu) 2002-03-28
KR20010101033A (ko) 2001-11-14
ID30064A (id) 2001-11-01
ZA200104081B (en) 2002-05-20
IL143177A0 (en) 2002-04-21
HUP0104139A3 (en) 2003-12-29
US20060149075A1 (en) 2006-07-06
CA2351727A1 (en) 2000-06-02
TR200202109T2 (tr) 2002-11-21
DE69929476T2 (de) 2006-09-14
AU1185100A (en) 2000-06-13
NO20012444D0 (no) 2001-05-18
PL348502A1 (en) 2002-05-20
CN1326449A (zh) 2001-12-12
TR200202103T2 (tr) 2002-11-21
ATE315552T1 (de) 2006-02-15
TWI250156B (en) 2006-03-01
US6541493B1 (en) 2003-04-01
US20030158241A1 (en) 2003-08-21
PT1131310E (pt) 2006-05-31

Similar Documents

Publication Publication Date Title
DE60037726D1 (de) Carbonsäurederivate die die bindung von integrinen an ihre rezeptoren hemmen
DK1203766T3 (da) Carboxylisyrederivater, der hæmmer bindingen af integriner til deres receptorer
ATE420876T1 (de) Propansäurederivate die die bindung von integrinen an ihre rezeptoren hemmen
RU93043528A (ru) Моногидрат 5-(2-(4-(1,2-бензотиазол-3-ил)-1-пиперазинил)этил)-6-хлор-1,3-дигидро-2н-индол-2-он хлоргидрата, способ его получения, фармацевтическая композиция, способ лечения
HUP0203841A3 (en) 5-membered heteroaromatic compounds and use thereof for preparation of pharmaceutical compositions, and pharmaceutical compositions containing them
FI933804A0 (fi) Monohydrat av 5-(2-(4-(1,2-bensisotiazol-3-yl)-1-piperazinyl)etyl-6-klor-1,3-dihydro-2h-indol-2-onkhydroklorid
CA2375201A1 (en) Crystal of (r)-lansoprazole
PL346220A1 (en) Compounds that inhibit the binding of integrins to their receptors
CA2119745A1 (en) Nonpeptidyl integrin inhibitors having specificity for gpiibiiia receptor
ITMI911953A0 (it) Procedimento di preparazione di composizione a cessione protratta e le composizioni cosi' ottenute
HUP0203431A3 (en) Novel heterocyclic compounds and salts thereof and pharmaceutical compositions containing and use of the same
TR200001793T2 (tr) Yapısında değişiklik yapılmış tiyazolidinediyon türevi, bunun hazırlanması için işlem ve eczacılık alanında kullanımı
NZ237884A (en) N-hydroxy-n-linolanyl (chromanyl or quinolinyl) alkyl urea and amide derivatives, preparation and pharmaceutical compositions thereof
NO922507L (no) Beleggssammensetning og fremgangsmaate for belegging av granulaer kunstgjoedsel med samme
DE69929476D1 (de) 5-ä(6-(2-fluorbenzyl)oxy-2-naphtyl)methylü-thiazolid in-2,4-dion kristallen
EA200000655A1 (ru) Гидрат соли малеиновой кислоты 5-[4-[2-(n-метил-n-(2-пиридил)амино)этокси]бензил]тиазолидин-2,4-диона
EA200101101A1 (ru) Новый фармацевтический препарат
ZA845723B (en) Compounds for lowering lipid levels
DK527585A (da) Monoethanolaminsaltet af n-(2-pyridyl)-2-methyl-4-hydroxy-2h-1,2-benzothiazin-3-carboxamid-1,1-dioxid paa saerlig krystallinsk form
CA2319359A1 (en) Utilization of powder preparations containing hydroxypyridones for treating leg ulcers and decubitus ulcers
NZ243552A (en) 2-[2-(4-methoxy-2-pyridinyl)phenylsulphinyl]-1h-benzimidazole derivatives, preparation and pharmaceutical compositions thereof
JPS57206683A (en) Pyrimidone salt, manufacture and medicinal composition containing same
JPS57140785A (en) Benzothiazine derivative, its preparation, and pharmaceutical composition containing the same

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee